Incorporating teleCBIT Into a Hospital-Based Tic Program
Sponsored by San Jose State University
About this trial
Last updated 7 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 7 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* age 5-65, diagnosis of Tourette Syndrome or other persistent tic disorder (per diagnostic interview and self-report of prior physician diagnosis)
* Clinical Global Impressions - Severity Score > 3 (i.e., "moderately ill" or worse),
* unmedicated or on stable medication treatment for tics and psychiatric problems,
* fluency in English
* a functional accessible home computer and high speed (i.e., cable/DSL) internet connection
* willingness to sign a release of information to contact a local, licensed medical or mental health provider, of whom they are currently a patient (in case of emergent safety concerns).
* Minor participants must have a parent or guardian who is fluent in English available to attend treatment and assessment sessions.
Exclusion Criteria
* significant suicidality, (i.e., a score of > 12 on the MINI or MINI-Kid suicidality module);
* prior diagnoses of intellectual disability; pervasive developmental disorder, mania, schizophrenia, psychotic disorder, substance abuse, substance dependence, or conduct disorder; currently experiencing a psychosocial, psychiatric, or neurological problem that requires immediate care
* lack of a functional home computer with high speed (i.e., cable or DSL) internet connection;
* or, prior receipt of >3 previous sessions of behavior therapy for tics within the past year (per self/parent report)
